JP2024533990A5 - - Google Patents

Info

Publication number
JP2024533990A5
JP2024533990A5 JP2024507995A JP2024507995A JP2024533990A5 JP 2024533990 A5 JP2024533990 A5 JP 2024533990A5 JP 2024507995 A JP2024507995 A JP 2024507995A JP 2024507995 A JP2024507995 A JP 2024507995A JP 2024533990 A5 JP2024533990 A5 JP 2024533990A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
formula
group
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024507995A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024533990A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/039696 external-priority patent/WO2023018648A1/en
Publication of JP2024533990A publication Critical patent/JP2024533990A/ja
Publication of JP2024533990A5 publication Critical patent/JP2024533990A5/ja
Pending legal-status Critical Current

Links

JP2024507995A 2021-08-09 2022-08-08 Brmの調節に使用するためのフェノール誘導体 Pending JP2024533990A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163231220P 2021-08-09 2021-08-09
US202163231219P 2021-08-09 2021-08-09
US63/231,219 2021-08-09
US63/231,220 2021-08-09
PCT/US2022/039696 WO2023018648A1 (en) 2021-08-09 2022-08-08 Phenol derivatives for use in the modulation of brm

Publications (2)

Publication Number Publication Date
JP2024533990A JP2024533990A (ja) 2024-09-18
JP2024533990A5 true JP2024533990A5 (cg-RX-API-DMAC7.html) 2025-08-18

Family

ID=83149068

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024507995A Pending JP2024533990A (ja) 2021-08-09 2022-08-08 Brmの調節に使用するためのフェノール誘導体

Country Status (8)

Country Link
US (2) US11993599B2 (cg-RX-API-DMAC7.html)
EP (1) EP4384517A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024533990A (cg-RX-API-DMAC7.html)
KR (1) KR20240046498A (cg-RX-API-DMAC7.html)
AU (1) AU2022328137A1 (cg-RX-API-DMAC7.html)
CA (1) CA3225467A1 (cg-RX-API-DMAC7.html)
TW (1) TW202321250A (cg-RX-API-DMAC7.html)
WO (1) WO2023018648A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024533990A (ja) 2021-08-09 2024-09-18 ジェネンテック, インコーポレイテッド Brmの調節に使用するためのフェノール誘導体
JP2025525340A (ja) * 2022-06-16 2025-08-05 プレキシウム インコーポレイテッド Swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily aを分解する化合物および医薬組成物
EP4695250A1 (en) 2023-04-12 2026-02-18 Aurigene Oncology Limited Tetracyclic compounds as smarca2 and/or smarca4 degraders

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA41598A (fr) 2015-02-25 2018-01-02 Constellation Pharmaceuticals Inc Composés thérapeutiques de pyridazine et leurs utilisations
SG11202104495YA (en) 2018-04-26 2021-05-28 Aurigene Discovery Tech Ltd Pyridazine derivatives as smarca2/4 degraders
WO2019213005A1 (en) 2018-04-30 2019-11-07 Dana-Farber Cancer Institute, Inc. Small molecule degraders of polybromo-1 (pbrm1)
US12454520B2 (en) 2018-07-06 2025-10-28 Kymera Therapeutics, Inc. Protein degraders and uses thereof
CN112996800B (zh) 2018-10-16 2024-06-25 勃林格殷格翰国际有限公司 作为smarca2和/或smarca4的降解剂的新型蛋白水解靶向嵌合体(protac)及其衍生物
FR3090393B1 (fr) 2018-12-20 2021-04-23 Ifp Energies Now Procédé de traitement d’une charge alcool pour la production d’oléfines
US20220143183A1 (en) 2019-02-23 2022-05-12 New York University Photoswitchable protacs and synthesis and uses thereof
US20220324880A1 (en) * 2019-06-10 2022-10-13 Kymara Therapeutics, Inc. Smarca inhibitors and uses thereof
US20230087825A1 (en) * 2019-06-10 2023-03-23 Kymera Therapeutics, Inc. Smarca degraders and uses thereof
US12624044B2 (en) 2019-06-10 2026-05-12 Kymera Therapeutics, Inc. SMARCA degraders and uses thereof
CA3150354A1 (en) 2019-09-12 2021-03-18 Muralidhara Ramachandra METHOD FOR IDENTIFYING RESPONDERS TO SMARCA2/4 DEGRADATION AGENTS
JP7502425B2 (ja) * 2019-10-01 2024-06-18 アルヴィナス・オペレーションズ・インコーポレイテッド Brm標的化化合物および関連使用方法
EP4054724A4 (en) * 2019-10-28 2023-12-27 C4 Therapeutics, Inc. BIFUNCTIONAL CONNECTIONS
CN114728936A (zh) * 2019-10-29 2022-07-08 豪夫迈·罗氏有限公司 用于治疗癌症的双功能化合物
CA3167166A1 (en) 2020-01-10 2021-07-15 Amgen Inc. Smarca2-vhl degraders
JP7508578B2 (ja) 2020-04-06 2024-07-01 フォグホーン セラピューティクス インコーポレイテッド 化合物及びその使用
PT4161935T (pt) * 2020-06-09 2025-08-14 Prelude Therapeutics Inc Compostos direcionados a brm e métodos de utilização associados
IL299860A (en) * 2020-07-21 2023-03-01 Genentech Inc Antibody-conjugated chemical factors for the discharge of BRM and their methods
US12552775B2 (en) 2020-11-20 2026-02-17 Foghorn Therapeutics Inc. Compounds and uses thereof
US12606568B2 (en) 2020-12-09 2026-04-21 Kymera Therapeutics, Inc. SMARCA degraders and uses thereof
US20240150755A1 (en) 2021-02-26 2024-05-09 Salk Institute For Biological Studies Modulating regulatory t cell function in autoimmune disease and cancer
JP2024533990A (ja) 2021-08-09 2024-09-18 ジェネンテック, インコーポレイテッド Brmの調節に使用するためのフェノール誘導体

Similar Documents

Publication Publication Date Title
CN114430740A (zh) Egfr抑制剂、组合物及其制备方法
JP2022550640A5 (cg-RX-API-DMAC7.html)
CN114430741A (zh) Egfr抑制剂、组合物及其制备方法
JP2013518888A5 (cg-RX-API-DMAC7.html)
RU2014122335A (ru) ХИНОЛИНКАРБОКСАМИДНЫЕ И ХИНОЛИНКАРБОНИТРИЛЬНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ mGluR2-НЕГАТИВНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ, КОМПОЗИЦИИ И ИХ ПРИМЕНЕНИЕ
RU2011101774A (ru) Новые замещенные пиридин-2-оны и пиридазин-3-оны
JP2021529814A5 (cg-RX-API-DMAC7.html)
JP2020529405A5 (cg-RX-API-DMAC7.html)
JP2018531218A5 (cg-RX-API-DMAC7.html)
RU2010136665A (ru) Новые пиридиноны и пиридазиноны
JP2010538094A5 (cg-RX-API-DMAC7.html)
RU2011103234A (ru) Новые фенилпиразиноны в качестве ингибиторов киназы
JP2017507160A5 (cg-RX-API-DMAC7.html)
JP2018535963A5 (cg-RX-API-DMAC7.html)
JP2012507522A5 (cg-RX-API-DMAC7.html)
JP2016500107A5 (ja) グルタミナーゼ阻害剤およびその使用方法
JP2014520108A5 (cg-RX-API-DMAC7.html)
JP2017531016A5 (cg-RX-API-DMAC7.html)
JP2022552445A5 (cg-RX-API-DMAC7.html)
CN111655678A (zh) 细胞凋亡信号调节激酶-1抑制剂及其应用
DE69425882T2 (de) 1-amino-3-phenoxy-propan-derivate als modulatoren bei multi-drug resistenz
JP2024502473A5 (cg-RX-API-DMAC7.html)
AU2021273001A1 (en) ENPP1 modulators and uses thereof
JP2023544404A5 (cg-RX-API-DMAC7.html)
JP2020535124A5 (cg-RX-API-DMAC7.html)